Peroxisome proliferator-activated receptor α induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-α activation properties

被引:103
|
作者
Teissier, E
Nohara, A
Chinetti, G
Paumelle, R
Cariou, B
Fruchart, JC
Brandes, RP
Shah, A
Staels, B
机构
[1] Inst Pasteur, Dept Atherosclerose, INSERM, UR545, F-59019 Lille, France
[2] Univ Lille 2, Fac Pharm, Lille, France
[3] Klinikum Goethe Univ, Frankfurt, Germany
[4] Kings Coll London, Dept Cardiol, GKT Sch Med, London WC2R 2LS, England
关键词
macrophages; nuclear receptors; NADPH oxidase; reactive oxygen species; inflammation;
D O I
10.1161/01.RES.0000150594.95988.45
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxisome proliferator - activated receptors (PPARs) are nuclear receptors controlling lipid and glucose metabolism as well as inflammation. PPARs are expressed in macrophages, cells that also generate reactive oxygen species (ROS). In this study, we investigated whether PPARs regulate ROS production in macrophages. Different PPAR-alpha, but not PPAR-gamma agonists, increased the production of ROS (H2O2 and O-2(radical anion)) in human and murine macrophages. PPAR-alpha activation did not induce cellular toxicity, but significantly decreased intracellular glutathione levels. The increase in ROS production was not attributable to inherent prooxidant effects of the PPAR-alpha agonists tested, but was mediated by PPAR-alpha, because the effects were lost in bone marrow - derived macrophages from PPAR-alpha(-/-) mice. The PPAR-alpha-induced increase in ROS was attributable to the induction of NADPH oxidase, because ( 1) preincubation with the NADPH oxidase inhibitor diphenyleneiodinium prevented the increase in ROS production; ( 2) PPAR-alpha agonists increased O-2(radical anion) production measured by superoxide dismutase - inhibitable cytochrome c reduction; ( 3) PPAR-alpha agonists induced mRNA levels of the NADPH oxidase subunits p47(phox), p67(phox), and gp91(phox) and membrane p47(phox) protein levels; and (4) induction of ROS production was abolished in p47(phox-/-) and gp91(phox-/-) macrophages. Finally, induction of NADPH oxidase by PPAR-alpha agonists resulted in the formation of oxidized LDL metabolites that exert PPAR-alpha-independent proinflammatory and PPAR-alpha - dependent decrease of lipopolysaccharide-induced inducible nitric oxide synthase expression in macrophages. These data identify a novel mechanism of autogeneration of endogenous PPAR-alpha ligands via stimulation of NADPH oxidase activity.
引用
收藏
页码:1174 / 1182
页数:9
相关论文
共 50 条
  • [31] Peroxisome proliferator-activated receptor-gamma (PPAR-γ) prevents ovarian cancer progression
    Rosen, Lauren E.
    Barua, Animesh
    Bahr, Janice M.
    Basu, Sanjib
    Sharma, Sameer
    Edassery, Seby E.
    Guirguis, Alfred S.
    Bitterman, Pincas
    CLINICAL CANCER RESEARCH, 2015, 21
  • [32] Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α) as a Regulator of the Angiogenic Profile of Endometriotic Lesions
    Pergialiotis, Vasilios
    Frountzas, Maximos
    Fasoulakis, Zacharias
    Daskalakis, George
    Chrisochoidi, Mairi
    Kontzoglou, Konstantinos
    Perrea, Despoina N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [33] Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview
    Ammazzalorso, Alessandra
    De Filippis, Barbara
    Giampietro, Letizia
    Amoroso, Rosa
    CHEMMEDCHEM, 2013, 8 (10) : 1609 - 1616
  • [34] Peroxisome proliferator-activated receptor γ (PPARγ) and colorectal carcinogenesis
    Ioannis A. Voutsadakis
    Journal of Cancer Research and Clinical Oncology, 2007, 133 : 917 - 928
  • [35] Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPAR-β/δ) Inhibits Human Breast Cancer Cell Line Tumorigenicity
    Yao, Pei-Li
    Morales, Jose L.
    Zhu, Bokai
    Kang, Boo-Hyon
    Gonzalez, Frank J.
    Peters, Jeffrey M.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (04) : 1008 - 1017
  • [36] ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-α IN SEPSIS
    Standage, S.
    Odoms, K.
    Denenberg, A.
    Zingarelli, B.
    Wong, H.
    SHOCK, 2010, 33 : 10 - 10
  • [37] Peroxisome proliferator-activated receptor (PPAR)γ agonists for diabetes
    Moller, DE
    Greene, DA
    ADVANCES IN PROTEIN CHEMISTRY, VOL 56: DRUG DISCOVERY AND DESIGN, 2001, 56 : 181 - +
  • [38] Peroxisome proliferator-activated receptor γ (PPARγ) and colorectal carcinogenesis
    Voutsadakis, Ioannis A.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (12) : 917 - 928
  • [39] The peroxisome proliferator-activated receptor α (PPARα):: role in hepatocarcinogenesis
    Gonzalez, FJ
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 193 (1-2) : 71 - 79
  • [40] Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans
    Hertz, R
    Bar-Tana, J
    TOXICOLOGY LETTERS, 1998, 103 : 85 - 90